Frontiers in Pharmacology | Neuropharmacology

Review

Published on 15 Mar 2024

Neuroinflammation alters GABAergic neurotransmission in hyperammonemia and hepatic encephalopathy, leading to motor incoordination. Mechanisms and therapeutic implications

in Neuropharmacology

Marta Llansola
Yaiza M. Arenas
María Sancho-Alonso
Gergana Mincheva
Andrea Palomares-Rodriguez
Magnus Doverskog
Paula Izquierdo-Altarejos
Vicente Felipo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1358323

3,532 views
12 citations

Original Research

Published on 14 Mar 2024

Probes for the heterogeneity of muscimol binding sites in rat brain

in Neuropharmacology

Veronika Müller
Margot Ernst
Aygul Baykuchkarova
Filip Koniuszewski
Konstantina Bampali
Thomas Seidel
Petra Scholze

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368527

1,690 views
1 citation

Correction

Published on 14 Mar 2024

Corrigendum: Phytotherapy for attention deficit hyperactivity disorder (ADHD): a systematic review and meta-analysis

in Neuropharmacology

Tusheema Dutta
Uttpal Anand
Shreya Sikdar Mitra
Mimosa Ghorai
Niraj Kumar Jha
Nusratbanu K. Shaikh
Mahipal S Shekhawat
Devendra Kumar Pandey
Jarosław Proćków
Abhijit Dey

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365806

1,774 views

Original Research

Published on 12 Mar 2024

Antiretroviral drugs from multiple classes induce loss of excitatory synapses between hippocampal neurons in culture

in Neuropharmacology

Hannah M. McMullan
Benjamin M. Gansemer
Stanley A. Thayer

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369757

1,745 views
1 citation

Review

Published on 08 Mar 2024

Dysregulation of sphingolipid metabolism in pain

in Neuropharmacology

Jianfeng Wang
Guangda Zheng
Linfeng Wang
Linghan Meng
Juanxia Ren
Lu Shang
Dongtao Li
Yanju Bao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1337150

2,646 views
8 citations

Original Research

Published on 07 Mar 2024

In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish

in Neuropharmacology

Ethan Bustad
Emma Mudrock
Elizabeth M. Nilles
Andrea Mcquate
Monica Bergado
Alden Gu
Louie Galitan
Natalie Gleason
Henry C. Ou
David W. Raible

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363545

3,189 views
2 citations

Original Research

Published on 01 Mar 2024

A peptide derived from TID1S rescues frataxin deficiency and mitochondrial defects in FRDA cellular models

in Neuropharmacology

Yi Na Dong
Lucie Vanessa Ngaba
Jacob An
Miniat W. Adeshina
Nathan Warren
Johnathan Wong
David R. Lynch

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352311

2,327 views
1 citation

Review

Published on 29 Feb 2024

Novel insight into the therapeutical potential of flavonoids from traditional Chinese medicine against cerebral ischemia/reperfusion injury

in Neuropharmacology

Jing Zhou
Feiyue Sun
Wenli Zhang
Zhitao Feng
Yi Yang
Zhigang Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352760

5,565 views
14 citations

Original Research

Published on 28 Feb 2024

In vitro characterization of novel hyaluronan-antioxidant conjugates as potential topical therapeutics against hearing loss

in Neuropharmacology

Elizabeth M. Arrigali
Joachim G. S. Veit
Bhaskar Birru
Jack Van Tine
Kolton C. Sandau
Emma Barrett-Catton
Zachary Tonnerre
Monica A. Serban

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355279

1,629 views
2 citations

Original Research

Published on 27 Feb 2024

Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson’s disease

in Neuropharmacology

Qing-Wei Ma
Rui-Ting Han
Zi-Jie Wu
Jun-Jie Zhou
Meng-Ting Chen
Xiang-Zhi Zhang
Wen-Zhe Ma
Na Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363212

2,218 views
3 citations

Original Research

Published on 26 Feb 2024

On propagation in networks, promising models beyond network diffusion to describe degenerative brain diseases and traumatic brain injuries

in Neuropharmacology

Davide Vergni
Paola Stolfi
Annalisa Pascarella

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1321171

1,246 views
1 citation

Mini Review

Published on 26 Feb 2024

Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes

in Neuropharmacology

Kethely L. Marques
Victor Rodrigues
Cassiana T. N. Balduci
Guilherme C. Montes
Penha C. Barradas
Marta C. Cunha-Rodrigues

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347529

5,029 views
4 citations

Original Research

Published on 23 Feb 2024

Intravenous Reelin rescues despair-like behavior, Reelin cells in the dentate sub-granular zone, and spleen atrophy in the cyclic corticosterone model of recurring depressive episodes

in Neuropharmacology

B. S. Reive
J. Johnston
C. L. Sánchez-Lafuente
Kaylene Scheil
K. Kurz
L. E. Kalynchuk
H. J. Caruncho

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368620

1,727 views
3 citations

Original Research

Published on 22 Feb 2024

Dl-3-n-butylphthalide attenuates cerebral ischemia/reperfusion injury in mice through AMPK-mediated mitochondrial fusion

in Neuropharmacology

Ting Zhu
Shanshan Dong
Na Qin
Rujuan Liu
Liuliu Shi
Qi Wan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357953

3,149 views
11 citations

Review

Published on 22 Feb 2024

Neurovascular effects of cocaine: relevance to addiction

in Neuropharmacology

Kevin Clare
Kicheon Park
Yingtian Pan
Carl W. Lejuez
Nora D. Volkow
Congwu Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357422

7,133 views
2 citations

Mini Review

Published on 21 Feb 2024

Established and emerging GABAA receptor pharmacotherapy for epilepsy

in Neuropharmacology

Robert J. Richardson
Steven Petrou
Alexander Bryson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341472

5,907 views
11 citations